Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unexpected Delayed Incursion of Highly Pathogenic Avian Influenza H5N1 (Clade 2.3.4.4b) Into the Antarctic Region.
Lisovski S, Günther A, Dewar M, Ainley D, Aldunate F, Arce R, Ballard G, Bauer S, Belliure J, Banyard AC, Boulinier T, Bennison A, Braun C, Cary C, Catry P, Clessin A, Connan M, Correia E, Cox A, Cristina J, Elrod M, Emerit J, Ferreiro I, Fowler Z, Gamble A, Granadeiro JP, Hurtado J, Jongsomjit D, Lesage C, Lejeune M, Kuepfer A, Lescroël A, Li A, McDonald IR, Menéndez-Blázquez J, Morandini V, Moratorio G, Militão T, Moreno P, Perbolianachis P, Pennycook J, Raslan M, Reid SM, Richards-Babbage R, Schmidt AE, Sander MM, Smyth L, Soutullo A, Stanworth A, Streith L, Tornos J, Varsani A, Herzschuh U, Beer M, Wille M. Lisovski S, et al. Among authors: smyth l. Influenza Other Respir Viruses. 2024 Oct;18(10):e70010. doi: 10.1111/irv.70010. Influenza Other Respir Viruses. 2024. PMID: 39420513 Free PMC article.
Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study.
Jhaveri KL, Lim E, Jeselsohn R, Ma CX, Hamilton EP, Osborne C, Bhave M, Kaufman PA, Beck JT, Manso Sanchez L, Parajuli R, Wang HC, Tao JJ, Im SA, Harnden K, Yonemori K, Dhakal A, Neven P, Aftimos P, Pierga JY, Lu YS, Larson T, Jerez Y, Sideras K, Sohn J, Kim SB, Saura C, Bardia A, Sammons SL, Bacchion F, Li Y, Yuen E, Estrem ST, Rodrik-Outmezguine V, Nguyen B, Ismail-Khan R, Smyth L, Beeram M. Jhaveri KL, et al. Among authors: smyth l. J Clin Oncol. 2024 Sep 6:JCO2302733. doi: 10.1200/JCO.23.02733. Online ahead of print. J Clin Oncol. 2024. PMID: 39241211
Community Health Synchronisation project.
Araujo N, Smyth L. Araujo N, et al. Among authors: smyth l. Perspect Public Health. 2024 Jul;144(4):219-221. doi: 10.1177/17579139241264945. Perspect Public Health. 2024. PMID: 39108132 No abstract available.
Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial.
See AW, Conway P, Frydenberg M, Haxhimolla H, Costello AJ, Moon D, Ruljancich P, Grummet J, Pranavan G, Peters J, Smyth LML, Gwini SM, McKenzie DP, Bowden P. See AW, et al. Among authors: smyth lml. Int J Cancer. 2024 Oct 1;155(7):1248-1256. doi: 10.1002/ijc.35052. Epub 2024 Jun 19. Int J Cancer. 2024. PMID: 38898626 Clinical Trial.
342 results